Localization and expression of cartilage oligomeric matrix protein by human rheumatoid and osteoarthritic synovium and cartilage

Synovium and cartilage from patients with osteoarthritis or rheumatoid arthritis were analyzed for expression of cartilage oligomeric matrix protein. Immunostaining of synovium with antiserum to cartilage oligomeric matrix protein demonstrated positive staining in both diseases. In osteoarthritis, there was positive staining within the synovial cells and immediately subjacent connective tissue, with less intense staining in the deeper connective tissue. In rheumatoid arthritis, there was less intense staining within the synovial cells and marked intense staining in the deeper connective tissue. In situ hybridization performed with an antisense digoxigenin‐labeled riboprobe to human cartilage oligomeric matrix protein confirmed the presence of cartilage oligomeric matrix protein mRNA in the cells of the synovial lining in both types of synovium. Quantitative polymerase chain reaction with a cartilage oligomeric matrix protein MIMIC demonstrated increased cartilage oligomeric matrix protein mRNA in rheumatoid cartilage and synovium as compared with osteoarthritic cartilage and synovium, respectively; mRNA levels in rheumatoid synovium were similar to those from osteoarthritic chondrocytes. As a result of the high expression of cartilage oligomeric matrix protein from rheumatoid synovium, inflammatory synovium should be considered as a potential tissue source of cartilage oligomeric matrix protein in any investigation of biological markers of cartilage metabolism. The upregulated expression of cartilage oligomeric matrix protein in inflammatory tissues suggests its in vivo regulation by cytokines.

[1]  R. Gay,et al.  Analysis of cartilage oligomeric matrix protein (COMP) in synovial fibroblasts and synovial fluids. , 1998, British journal of rheumatology.

[2]  C. White,et al.  Regulation of cartilage oligomeric matrix protein synthesis in human synovial cells and articular chondrocytes. , 1998, Arthritis and rheumatism.

[3]  J. Funk,et al.  Synovium as a source of increased amino-terminal parathyroid hormone-related protein expression in rheumatoid arthritis. A possible role for locally produced parathyroid hormone-related protein in the pathogenesis of rheumatoid arthritis. , 1998, The Journal of clinical investigation.

[4]  C. Mohan,et al.  Genetic dissection of SLE pathogenesis. Sle1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucleosomes. , 1998, The Journal of clinical investigation.

[5]  R. Holmdahl,et al.  Increased serum levels of cartilage oligomeric matrix protein in chronic erosive arthritis in rats , 1998, Arthritis and rheumatism.

[6]  T. Saxne,et al.  Cartilage macromolecules in knee joint synovial fluid. Markers of the disease course in patients with acute oligoarthritis , 1997, Annals of the rheumatic diseases.

[7]  L. Klareskog,et al.  Increased serum levels of cartilage oligomeric matrix protein and bone sialoprotein in rats with collagen arthritis. , 1997, British journal of rheumatology.

[8]  M. Paulsson,et al.  Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. , 1997, British journal of rheumatology.

[9]  T. Saxne,et al.  Tissue-derived macromolecules and markers of inflammation in serum in early rheumatoid arthritis: relationship to development of joint destruction in hands and feet. , 1997, British journal of rheumatology.

[10]  P. D. Di Cesare,et al.  Expression of cartilage oligomeric matrix protein by human synovium , 1997, FEBS letters.

[11]  M. Paulsson,et al.  Increased degradation and alteered tissue distribution of cartilage oligomeric matrix protein in human rheumatoid and osteoarthritic cartilage , 1996, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[12]  K. Brandt,et al.  Accelerated clearance of albumin from the osteoarthritic knee: implications for interpretation of concentrations of "cartilage markers" in synovial fluid. , 1996, The Journal of rheumatology.

[13]  F. Wollheim Predictors of joint damage in rheumatoid arthritis * , 1996, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[14]  M. Paulsson,et al.  Cartilage oligomeric matrix protein: Isolation and characterization from human articular cartilage , 1995, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[15]  P. Dieppe,et al.  Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint. , 1995, British journal of rheumatology.

[16]  B. Månsson,et al.  Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. , 1995, The Journal of clinical investigation.

[17]  D. Heinegård,et al.  Cartilage metabolism in the injured and uninjured knee of the same patient. , 1994, Annals of the rheumatic diseases.

[18]  G. Newton,et al.  Characterization of human and mouse cartilage oligomeric matrix protein. , 1994, Genomics.

[19]  M. Paulsson,et al.  Cartilage oligomeric matrix protein (COMP) is an abundant component of tendon , 1994, FEBS letters.

[20]  M. Paulsson,et al.  Cartilage oligomeric matrix protein and thrombospondin 1. Purification from articular cartilage, electron microscopic structure, and chondrocyte binding. , 1994, European journal of biochemistry.

[21]  D. Heinegård,et al.  Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis. , 1994, Annals of the rheumatic diseases.

[22]  D. Heinegård,et al.  COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. , 1992, The Journal of biological chemistry.

[23]  T. Saxne,et al.  Increased serum concentrations of cartilage oligomeric matrix protein. A prognostic marker in early rheumatoid arthritis. , 1992, British journal of rheumatology.

[24]  D. Heinegård,et al.  Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. , 1992, British journal of rheumatology.

[25]  J Engel,et al.  Electron microscopy of native cartilage oligomeric matrix protein purified from the Swarm rat chondrosarcoma reveals a five-armed structure. , 1992, The Journal of biological chemistry.

[26]  D. Heinegård,et al.  Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. , 1992, The Journal of biological chemistry.

[27]  A. Ratcliffe,et al.  Biochemical markers of osteoarthritis. , 1990, Current opinion in rheumatology.

[28]  D. Heinegård,et al.  Noncollagenous cartilage proteins current status of an emerging research field. , 1984, Collagen and related research.

[29]  D. Goldenberg,et al.  Inflammatory synovitis in degenerative joint disease. , 1982, The Journal of rheumatology.

[30]  D. Heinegård,et al.  Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint. , 1998, British journal of rheumatology.

[31]  R. Gay,et al.  Mechanism of joint destruction in rheumatoid arthritis. , 1998, Archivum immunologiae et therapiae experimentalis.

[32]  D. Heinegård,et al.  Release of cartilage macromolecules into the synovial fluid in patients with acute and prolonged phases of reactive arthritis. , 1993, Arthritis and rheumatism.